IKZF1 and tuberculosis: As Ikaros expression is significantly reduced in TB splenocytes, we treated naïve splenocytes with the proteasomal inhibitor, MG132, which was used as a molecular tool to test whether Ikaros protein undergoes proteasomal degradation.